Employee Benefit Plans (Tables)

9 Months Ended

Mar. 31, 2023

Share Based Compensation [Abstract]

Common Stock Reserved for Future Issuance

The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):

	March 31, 2023		June 30, 2022
2013 Equity Incentive Plan shares available for grant		10,701		11,430
Employee stock options and awards outstanding		9,995		7,616
2014 Employee Stock Purchase Plan		8,467		9,961
Total shares reserved for issuance		29,163		29,007

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	March 31, 2023		March 31, 2022		March 31, 2023		March 31, 2022
Cost of product revenues	$	492	$	291	$	1,365	$	904
Cost of service and subscription revenues		930		343		2,568		1,056
Research and development		3,883		2,446		10,935		7,568
Sales and marketing		5,777		3,832		16,326		11,267
General and administrative		4,294		3,941		15,367		11,835
Total share-based compensation expense	$	15,376	$	10,853	$	46,561	$	32,630

Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended March 31, 2023 (in thousands, except per share and contractual term):

	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2022		1,187	$	6.56		3.70	$	2,801
Granted		—		—
Exercised		—		—
Canceled		—		—
Options outstanding at March 31, 2023		1,187	$	6.56		2.95	$	14,909
Vested and expected to vest at March 31, 2023		1,187	$	6.56		2.95	$	14,909
Exercisable at March 31, 2023		1,108	$	6.55		2.91	$	13,921

Summary of Stock Award Activity

The following table summarizes stock award activity for the nine months ended March 31, 2023 (in thousands, except grant date fair value):

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Value
Non-vested stock awards outstanding at June 30, 2022		6,429		$	9.57
Granted		6,400			14.65
Released		(3,285	)		8.42
Canceled		(736	)		12.70
Non-vested stock awards outstanding at March 31, 2023		8,808		$	13.43	$	168,413
Stock awards expected to vest at March 31, 2023		8,808		$	13.43	$	168,413

Schedule of Awards Performance Thresholds and Shares Expected to Vest (TSR PSUs)

The MSU award represents the right to receive a target number of shares of common stock of up to 150% of the original grant, as indicated in the table below. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods of three years from the grant date, subject to the grantees’ continued service through the certification of performance.

Level	Relative TSR	Shares Vested
Below Threshold	TSR is less than the Index by more than 37.5 percentage points	0%
Threshold	TSR is less than the Index by 37.5 percentage points	25%
Target	TSR equals the Index	100%
Maximum	TSR is greater than the Index by 25 percentage points or more	150%

Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards

The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:

	Employee Stock Purchase Plan						Employee Stock Purchase Plan
	Three Months Ended						Nine Months Ended
	March 31, 2023			March 31, 2022			March 31, 2023			March 31, 2022
Expected term	0.5 years			0.5 years			0.5 years			0.5 years
Risk-free interest rate		4.98	%		0.67	%		3.84	%		0.33	%
Volatility		49	%		45	%		55	%		49	%
Dividend yield		—	%		—	%		—	%		—	%